Document Detail

Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video).
MedLine Citation:
PMID:  25085333     Owner:  NLM     Status:  Publisher    
BACKGROUND: Endoscopic volume reduction of the stomach may provide a minimally invasive alternative for surgical procedures in the treatment of obesity.
OBJECTIVE: To assess safety and preliminary effectiveness in the first human application of a novel endoscopic stapling technique.
DESIGN: Prospective, observational, phase 1 study.
SETTING: Two university hospitals in The Netherlands.
PATIENTS: Patients with a body mass index (BMI) of 40 to 45 kg/m(2) or 30 to 39.9 kg/m(2) with obesity-related comorbidity.
INTERVENTIONS: Gastric volume reduction with an endoscopic stapler.
MAIN OUTCOME MEASUREMENTS: Primary outcome measure was the prevalence of serious or mild adverse events. Reduction of excess body weight after 12 months was assessed as a secondary outcome measure for effectiveness of the procedure.
RESULTS: Seventeen patients with a median BMI of 40.2 kg/m(2) (interquartile range [IQR] 37.6-42.8) underwent an endoscopic stapling procedure. Median procedure time was 123 minutes (IQR 95-129). No serious adverse events occurred. Adverse events were gastric pain (n = 7, range 1-3 days), sore throat (n = 4, 2-3 days), diarrhea (n = 4, 2-15 days), nausea (n = 3, 2-4 days), constipation (n = 4, 3-14 days), and vomiting (n = 3, 1-4 days). All adverse events were mild and resolved with conservative treatment within 15 days after surgery. The median percentage excess weight loss in the first year was 34.9% (IQR 17.8-46.6).
LIMITATIONS: Limited number of patients.
CONCLUSION: This first human application of this endoscopic stapler demonstrates that the procedure is technically feasible and safe. One hundred sixty plications were created in 17 patients without significant problems. Weight loss after 1 year is promising, but long-term follow-up and randomized, controlled studies should evaluate whether this procedure is an effective and durable minimally invasive endoscopic treatment for obesity. (Clinical trial registration number: NCT01429194.).
Tessa Verlaan; Givan F Paulus; Elisabeth M H Mathus-Vliegen; Elisabeth A M L Veldhuyzen; José M Conchillo; Nicole D Bouvy; Paul Fockens
Related Documents :
19279273 - Long-term outcome of tandem stenting for stenoses of the intracranial vertebrobasilar a...
14530633 - Early functional recovery and the fate of the diffusion/perfusion mismatch in patients ...
23032593 - Long-term results after distal rectus femoris transfer as a part of multilevel surgery ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-29
Journal Detail:
Title:  Gastrointestinal endoscopy     Volume:  -     ISSN:  1097-6779     ISO Abbreviation:  Gastrointest. Endosc.     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-8-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0010505     Medline TA:  Gastrointest Endosc     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of carcinomatosis and ascites status on long-term outcomes of palliative treatment for patien...
Next Document:  Simplified magnetic anchor-guided endoscopic submucosal dissection in dogs (with videos).